Publications

Julg, Boris, Kathryn E. Stephenson, Kshitig Wagh-, -Bette Korber, and Dan H. Barouch. 2022. “Safety and Antiviral Activity of Triple Combination Broadly Neutralizing Monoclonal Antibody Therapy Against HIV-1: A Phase 1 Clinical Trial”. Nature Medicine 28 (6): 1288-96.

Tostanoski, Lisa H., Abishek Chandrashekar, Shivani Patel-, -Kathryn E. Stephenson-, -Hanneke Schuitemaker, and Dan H. Barouch. 2022. “Passive Transfer of Ad26.COV2.S-Elicited IgG from Humans Attenuates SARS-CoV-2 Disease in Hamsters”. NPJ Vaccines 7 (1): 2.

Marcelin, Jasmine R., Audrey Pettifor, Holly Janes, Elizabeth R. Brown, James G. Kublin, and Kathryn E. Stephenson. 2022. “COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective.”

Stephenson, Kathryn E. 2022. “Novel Chikungunya Vaccine Shows Promise for Durable Protection”. Lancet Infectious Diseases 22 (9): 1259-61.

Stephenson, Kathryn E., Boris Julg, Sabrina Tan-, -Bette Korber, and Dan H. Barouch. 2021. “Safety, Pharmacokinetics and Antiviral Activity of PGT121, a Broadly Neutralizing Monoclonal Antibody Against HIV-1: A Randomized, Placebo-Controlled, Phase 1 Clinical Trial”. Nature Medicine 27: 1718-24.

Stephenson, Kathryn, Mathieu Le Gars, Jerald Sadoff-, -Hanneke Schuitemaker, and Dan H. Barouch. 2021. “Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.”. JAMA 325(15):1535-1544.

Burwick, Richard M., Sigal Yawetz, Kathryn E. Stephenson-, -Rebecca Zash, and William R. Short. 2021. “Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019”. Clinical Infectious Diseases 73 (11): e3996-e4004.

Ojikutu, Bisola O., Kathryn E. Stephenson, Kenneth H. Mayer, and Karen M. Emmons. 2021. “Building Trust in COVID-19 Vaccines and Beyond Through Authentic Community Investmen”. American Journal of Public Health 111 (3): 366-68.

Sadoff, Jerald, Mathieu Le Gars, Georgi Shukarev-, -Kathryn E. Stephenson-, -Johan van Hoof, and Hanneke Schuitemaker. 2021. “Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine”. New England Journal of Medicine 384 (19): 1824-35.

Salisch, Nadine C., Kathryn E. Stephenson, Kristi Williams-, -Hanneke Schuitemaker, and Dan H. Barouch. 2021. “A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine”. Annals of Internal Medicine 714 (5): 585-94.